Heidelberg Pharma AG (HPHA.DE) Stock Price
€4.38 0%
to add to portfolio
AI Score

-
Alternative
8 -
Fundamental
1 -
Technical
7
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Heidelberg Pharma AG, AI stock picks, stock alerts and much more.
HPHA.DE AI Stock Analysis
AI stock analysis for HPHA.DE is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Heidelberg Pharma AG (HPHA.DE) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Heidelberg Pharma AG (HPHA.DE) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Heidelberg Pharma AG (HPHA.DE), currently trading at €4.38, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About HPHA.DE

-
Heidelberg Pharma AG, a biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, other European countries, the United States, and internationally.
-
Symbol
HPHA.DE
-
Market
XETRA
-
Industry
Biotechnology
-
Market Cap
204.8M
Similar Stocks
![]() |
CureVac 5CV.F |
€4.69 1% |
5 |
![]() |
BioNTech SE 22UA.F |
€91.85 4.1% |
5 |
![]() |
Novavax NVV1.F |
€6.46 3.6% |
3 |
![]() |
Formycon AG FYB.DE |
€24.6 0.4% |
6 |
![]() |
BRAIN Biotech AG BNN.DE |
€2.2 5.3% |
4 |
HPHA.DE Alternative Data
Web Traffic
Heidelberg Pharma AG receives an estimated 4585 monthly visitors to heidelberg-pharma.com.
-
Web Traffic
4585
-
Change from Previous Month
21.2%
-
3 Month Change
65.8%
-
YoY Change
65.8%
Job Postings
Heidelberg Pharma AG currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
Heidelberg Pharma AG has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
6,144 are following Heidelberg Pharma AG on LinkedIn, up by 1.9% over the last month.
-
LinkedIn Followers
6144
-
Daily Change
1.9%
-
1 Month Change
1.9%
-
3 Month Change
6.7%
-
YoY Change
6.7%
LinkedIn Employees
According to LinkedIn, Heidelberg Pharma AG has 47 employees.
-
LinkedIn Employees
47
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
4.1%
-
YoY Change
4.1%
Business Outlook
According to employee reviews, the business outlook among employees at Heidelberg Pharma AG is 100 out of 100 (very bullish).
-
Business Outlook
100
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Heidelberg Pharma AG was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Twitter Followers
Heidelberg Pharma AG has 172 Twitter Followers on its main Twitter (also known as X) account.
-
Twitter Followers
172
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
HPHA.DE Financials
HPHA.DE Key Metrics
-
Total Revenue
€1.3M
-
Net Income
-€5.9M
-
Earnings per Share
-€0.13
-
Free cash flow
-€8.7M
-
EBITDA
-€5.7M
-
EBITDA Ratio
-4.49692
-
Total Assets
€52.8M
HPHA.DE 2-year Revenue & Income
HPHA.DE 2-year Free Cash Flow
HPHA.DE Technicals
HPHA.DE SMA
HPHA.DE RSI
FAQ
What's the current price of Heidelberg Pharma AG (HPHA.DE) Stock?
The price of an Heidelberg Pharma AG (HPHA.DE) share is €4.38.
What's the market cap of Heidelberg Pharma AG?
The current market cap of Heidelberg Pharma AG is 204.8M.
Should I buy or sell HPHA.DE?
Multiple alternative data signals suggest that Heidelberg Pharma AG stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Heidelberg Pharma AG a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Heidelberg Pharma AG stock. The bullish indicators suggest that Heidelberg Pharma AG's growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Heidelberg Pharma AG (HPHA.DE) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Heidelberg Pharma AG stock, given the bullish outlook.
What are some stocks similar to Heidelberg Pharma AG (HPHA.DE) that investors often compare it to?
Heidelberg Pharma AG (HPHA.DE) is often compared to similar stocks such as CureVac, BioNTech SE, Novavax, Formycon AG and BRAIN Biotech AG.
What is the forecast for Heidelberg Pharma AG's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Heidelberg Pharma AG's stock price to be around €4.66 in 2026. Starting from the current price of €4.38, this represents a 6.3% change in price, indicating a bullish outlook for the stock.
How to buy Heidelberg Pharma AG (HPHA.DE) Stock?
Heidelberg Pharma AG stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Heidelberg Pharma AG shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.